Home > Boards > US OTC > Medical - Drugs > Elite Pharmaceuticals (ELTP)

News From The Meeting

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
BS Sifter Member Profile
 
Followed By 31
Posts 1,162
Boards Moderated 0
Alias Born 10/12/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 5:31:18 PM
Elite Pharmaceuticals reports FQ2 results Seeking Alpha - 11/15/2021 4:51:51 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/15/2021 4:12:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 5:29:36 PM
Elite Pharmaceuticals reports Q1 results Seeking Alpha - 8/16/2021 5:05:15 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:22:36 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 5:01:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:37:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:31:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:21:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2021 5:16:46 PM
Elite Pharmaceuticals reports FY results Seeking Alpha - 6/14/2021 5:16:14 PM
Annual Report (10-k) Edgar (US Regulatory) - 6/14/2021 5:01:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/19/2021 1:29:31 PM
Elite Pharmaceuticals enters exclusive distribution agreement with Prasco Seeking Alpha - 5/4/2021 10:32:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/29/2021 4:02:41 PM
Elite Pharmaceuticals names Marc Bregman as chief financial officer Seeking Alpha - 4/29/2021 8:56:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/12/2021 6:16:33 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/16/2021 5:04:10 PM
Elite Pharmaceuticals reports FQ3 results Seeking Alpha - 2/16/2021 4:41:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/16/2021 4:23:16 PM
BS Sifter   Friday, 05/23/14 07:32:30 PM
Re: None
Post # of 362633 
News From The Meeting

There was one thing that was discussed that resonated with me very well. During the Q&A session a person asked if the recent demand from the public, legislators, and FDA for abuse resistant opioids was favorable for ELTP.

NH, without hesitation, said yes. He then went on to say that the table has been set for us and if we don't get a product to market then "shame on us." Basically he's saying we are here at he right time, with the right product and the know-how to make it happen. It would be very difficult to screw this up.

NH, Jerry & co are very confident, determined, and optimistic of the task they are undertaking and what they plan to achieve. NH has a clear plan and vision of where this is all going.

NH was very confident in his answers, looking people straight in the eye, not much blinking, squirming or anything else that would indicate something was wrong. He's a hell of a guy, good guy, honest and intelligent.

Again, I do commercial loans - prime and subprime in the nj/NYC area. You cannot imagine the characters I deal with. I rarely have a default. I know people, I see through people like looking through a window. I know when people are good and I know when they are dirtbags.

I sat in front of the whole board at the meeting and did my best to analyze all of them. I spoke with them afterwards, shook their hands and looked them in the eye. These are good, intelligent, honest people. I feel a lot better with my investment after going to the meeting.

Nothing is guaranteed, but I know these people will do everything they can to make us all succeed.

Be a man of honor. Have some guts. Do the right thing, speak the truth and stand up for what's right. It's amazing how some can do what they do and still manage to look at themselves in the mirror. These lowlifes have no pride, self-respect, or shame.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences